A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.
Ohnishi T, Yamada K, Ohba H, Iwayama Y, Toyota T, Hattori E, Inada T, Kunugi H, Tatsumi M, Ozaki N, Iwata N, Sakamoto K, Iijima Y, Iwata Y, Tsuchiya KJ, Sugihara G, Nanko S, Osumi N, Detera-Wadleigh SD, Kato T, Yoshikawa T.
Ohnishi T, et al. Among authors: ohba h.
Neuropsychopharmacology. 2007 Aug;32(8):1727-37. doi: 10.1038/sj.npp.1301307. Epub 2007 Jan 24.
Neuropsychopharmacology. 2007.
PMID: 17251911